FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Open accessThe DOI matches its Crossref record; 107 of the 109 references it cites were found in a registry or an index.
Abstract
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European and American guidelines for PET/CT imaging recommended the measurement of blood glucose level prior to scanning and rescheduling the examination whenever the level exceeds 200 mg/dL.[5,6]”
From Intrapatient variability of 18F-FDG uptake in normal tissues (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although all these errors are potentially severe, it should be noted that they can easily be avoided by following existing guidelines published by the EANM [24] or the EANM Research Ltd. (EARL) initiative [67].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interpretation of PET images in routine clinical practice primarily follows visual criteria, i.e., the assessment of generalized or focal pathologies in tracer accumulation, while quantitative parameters, including SUV, provide orientation or additional information at most [24].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“European Association of Nuclear Medicine (EANM) [40] guidelines suggest if the plasma glucose level is higher than or equal to 200 mg/dl, the FDG PET/CT study should be rescheduled.”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current available PET-scan preparation protocols suggest rescheduling the scan or consideration of rapid-acting insulin injection prior to PET scan or scan rescheduling in patients with hyperglycemia ranging from 120 mg/dl to 200 mg/dl, and recommend inconsistent and diverse cut-offs for insulin injection or scan rescheduling [39,40].”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777 · cited 8×
“2-cm diameter (or 1-mL volume) spherical VOI [61] positioned such that the average value across all positions within the lesion is maximized.”
InfluentialUniversity of California, San Francisco
(1974) · Medical History · doi:10.1017/s0025727300019682 · Cited by 2,222
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Self-citationBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665 · cited 1×
“Further, a fivepoint scale has been proposed for assessment of lymphoma therapy response [80].”
Self-citationJuweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335 · cited 2×
“Some criteria have already been proposed [78, 79].”
Self-citationFDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326 · cited 6×
“• The effects of growth factors (G-CSF and GM-CSF) on FDG biodistribution (due to enhanced bone marrow uptake) generally last for more than 2 weeks after the final administration [20].”
InfluentialSelf-citationRecommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Self-citationStandards for PET Image Acquisition and Quantitative Data Analysis
Boellaard, R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057182 · Cited by 902 · cited 4×
“This requires reconstruction settings to be chosen such as to achieve matching convergence and spatial resolution across various systems and sites, especially within a multicentre setting [48, 58, 59].”
InfluentialSelf-citationQuantification of Lean Bodyweight
Janmahasatian, S., Duffull, S. B., Ash, S., Ward, L. C., Byrne, N. M., & Green, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00004 · Cited by 900 · cited 1×
“[62]: LBM = 9,270 × weight/(6,680 + 216 × BMI) LBM = 9,270 × weight/(8,780 + 244 × BMI) where LBM and LBM are the LBM for males and females, and BMI is body mass index (weight/height), and weight and height are in kilograms and centimetres, respectively.”
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 765
Self-citation
Research works printed but not linked: 1
- 77. Padhani AR. Imaging in the evaluation of cancer. In: Nicholson T, editor. Recommendations for cross-sectional imaging in cancer management. 2nd ed. London: The Royal College of Radiologists; 2014.
Cited by
Items 101–143 of 143
Beukinga, R. J., Hulshoff, J. B., Mul, V. E. M., Noordzij, W., Kats-Ugurlu, G., Slart, R. H. J. A., & Plukker, J. T. M. (2018) · Radiology · doi:10.1148/radiol.2018172229 · Cited by 114
Fanti, S., Minozzi, S., Morigi, J. J., Giesel, F., Ceci, F., Uprimny, C., Hofman, M. S., Eiber, M., Schwarzenbock, S., Castellucci, P., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3725-1 · Cited by 113
Self-citationEskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
Quak, E., Le Roux, P.-Y., Hofman, M. S., Robin, P., Bourhis, D., Callahan, J., Binns, D., Desmonts, C., Salaun, P.-Y., Hicks, R. J., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3128-0 · Cited by 107
“ters, as well as compliance to EANM guidelines for PET tumour imaging [7], were also analysed.”
MethodRole of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology
Ziai, P., Hayeri, M. R., Salei, A., Salavati, A., Houshmand, S., Alavi, A., & Teytelboym, O. M. (2016) · RadioGraphics · doi:10.1148/rg.2016150102 · Cited by 106
PET in the management of locally advanced and metastatic NSCLC
Grootjans, W., de Geus-Oei, L.-F., Troost, E. G. C., Visser, E. P., Oyen, W. J. G., & Bussink, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.75 · Cited by 97
Self-citationNuclear medicine and molecular imaging advances in the 21st century
Vaz, S. C., Oliveira, F., Herrmann, K., & Veit-Haibach, P. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20200095 · Cited by 86
Boccalini, C., Ribaldi, F., Hristovska, I., Arnone, A., Peretti, D. E., Mu, L., Scheffler, M., Perani, D., Frisoni, G. B., & Garibotto, V. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13355 · Cited by 82
Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Sprinz, C., Altmayer, S., Zanon, M., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193140 · Cited by 82
Quantitative implications of the updated EARL 2019 PET–CT performance standards
Kaalep, A., Burggraaff, C. N., Pieplenbosch, S., Verwer, E. E., Sera, T., Zijlstra, J., Hoekstra, O. S., Oprea-Lager, D. E., & Boellaard, R. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0257-8 · Cited by 79
“Reconstructed data were analysed using a semi-automatic tool developed for EARL [16].”
MethodSelf-citationReduction of 18 F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier Detectors
Sekine, T., Delso, G., Zeimpekis, K. G., de Galiza Barbosa, F., ter Voert, E. E. G. W., Huellner, M., & Veit-Haibach, P. (2018) · Radiology · doi:10.1148/radiol.2017162305 · Cited by 79
“The CT component is used both for attenuation correction and for anatomic correlation and characterization of lesions with pathologic radiotracer uptake (3).”
BackgroundMethodPerformance Characteristics of the Whole-Body Discovery IQ PET/CT System
Reynés-Llompart, G., Gámez-Cenzano, C., Romero-Zayas, I., Rodríguez-Bel, L., Vercher-Conejero, J. L., & Martí-Climent, J. M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185561 · Cited by 78
“and settings should especially be considered when standardization and harmonization are required, as is the case in multicenter studies (19).”
BackgroundAlberts, I., Sachpekidis, C., Prenosil, G., Viscione, M., Bohn, K. P., Mingels, C., Shi, K., Ashar-Oromieh, A., & Rominger, A. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-021-01588-6 · Cited by 70
Kramer, G. M., Frings, V., Hoetjes, N., Hoekstra, O. S., Smit, E. F., de Langen, A. J., & Boellaard, R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170225 · Cited by 65
“For correspondence or reprints contact: Gerbrand Maria Kramer, Department of Radiology and Nuclear Medicine, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.”
MethodInfluentialSelf-citationCottereau, A.-S., Hapdey, S., Chartier, L., Modzelewski, R., Casasnovas, O., Itti, E., Tilly, H., Vera, P., Meignan, M. A., & Becker, S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180406 · Cited by 64
“Even if the prerequisite for this type of trial is quality control, as done using various existing control systems (7,19,20), it is anyway required for good PET clinical practice.”
BackgroundMethodBoellaard, R., Rausch, I., Beyer, T., Delso, G., Yaqub, M., Quick, H. H., & Sattler, B. (2015) · Medical Physics · doi:10.1118/1.4930962 · Cited by 62
Self-citationSprinz, C., Zanon, M., Altmayer, S., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-20529-4 · Cited by 59
Influences on PET Quantification and Interpretation
Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C.-A., Boellaard, R., & Kobe, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020451 · Cited by 57
“, the assessment of generalized or focal pathologies in tracer accumulation, while quantitative parameters, including SUV, provide orientation or additional information at most [24].”
BackgroundMethodInfluentialSelf-citationKluge, R., Chavdarova, L., Hoffmann, M., Kobe, C., Malkowski, B., Montravers, F., Kurch, L., Georgi, T., Dietlein, M., Wallace, W. H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149072 · Cited by 56
Reynés‐Llompart, G., Gámez‐Cenzano, C., Vercher‐Conejero, J. L., Sabaté‐Llobera, A., Calvo‐Malvar, N., & Martí‐Climent, J. M. (2018) · Medical Physics · doi:10.1002/mp.12986 · Cited by 55
“5 kBq/cm.(3) The four smaller spheres were filled with three LBR of 2:1, 4:1, and 8:1.”
BackgroundCaribé, P. R. R. V., Koole, M., D’Asseler, Y., Van Den Broeck, B., & Vandenberghe, S. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0264-9 · Cited by 51
Trägårdh, E., Minarik, D., Almquist, H., Bitzén, U., Garpered, S., Hvittfelt, E., Olsson, B., & Oddstig, J. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0535-4 · Cited by 50
Viglianti, B. L., Wong, K. K., Wimer, S. M., Parameswaran, A., Nan, B., Ky, C., Townsend, D. M., Rubello, D., Frey, K. A., & Gross, M. D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.166 · Cited by 48
te Riet, J., Rijnsdorp, S., Roef, M. J., & Arends, A. J. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0262-y · Cited by 46
“Images of the NEMA phantom were analyzed using the EARL analysis tool with a VOI50 isocontour (3D isocontour at 50% of maximum pixel value, corrected for background uptake [1, 24]) and data of the MHS phantom were analyzed by a custom-written macro in FIJI [25] giving results similar to the EARL analysis tool.”
BackgroundMethodLiu, Z., Li, M., Zuo, C., Yang, Z., Yang, X., Ren, S., Peng, Y., Sun, G., Shen, J., Cheng, C., et al. (2021) · European Radiology · doi:10.1007/s00330-021-07778-0 · Cited by 46
“tion [37, 38], standardize data collection procedures[39], avoid the influence of different platforms and subject-related factors (such as respiratory motion artifacts [40–42]), and pro-”
BackgroundWen, W., Xuan, D., Hu, Y., Li, X., Liu, L., & Xu, D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225959 · Cited by 44
“According to the guidelines and protocols for 18 F-FDG PET imaging, heterogeneity of PET/CT parameters (duration of fasting, preinjection blood glucose test, post-injection interval, and dose of (18)F-FDG) included in this study were acceptable as the values were within normal range [3, 38, 39](Table 2).”
MethodTakemiya, K., Ning, X., Seo, W., Wang, X., Mohammad, R., Joseph, G., Titterington, J. S., Kraft, C. S., Nye, J. A., Murthy, N., et al. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.02.011 · Cited by 40
“Data were analyzed using the ratios of the SUV to account for differences in body weight as previously described (14,15).”
MethodHoudu, B., Lasnon, C., Licaj, I., Thomas, G., Do, P., Guizard, A.-V., Desmonts, C., & Aide, N. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4151-8 · Cited by 37
Castello, A., Rossi, S., Toschi, L., & Lopci, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061251 · Cited by 36
“(EARL) accredited scanners: (a) Siemens Biograph LSO 6 scanner (Siemens Erlangen; Munich, Germany), with an integrated 6-slice CT, and (b) GE Discovery PET/CT 690 (General Electric Healthcare; Waukesha, WI, USA), with an integrated 64-slice CT [20].”
MethodReynés-Llompart, G., Sabaté-Llobera, A., Llinares-Tello, E., Martí-Climent, J. M., & Gámez-Cenzano, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46937-8 · Cited by 35
Ly, J., Minarik, D., Edenbrandt, L., Wollmer, P., & Trägårdh, E. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0536-3 · Cited by 31
Effect of evogliptin on the progression of aortic valvular calcification
Song, J.-K., Lee, S., Kim, Y.-J., Kim, H.-K., Ha, J.-W., Choi, E.-Y., Park, S.-W., Park, S.-J., Park, Y.-H., Park, J.-H., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.037 · Cited by 28
Ceriani, L., Barrington, S., Biggi, A., Malkowski, B., Metser, U., Versari, A., Martelli, M., Davies, A., Johnson, P. W., Zucca, E., et al. (2017) · Hematological Oncology · doi:10.1002/hon.2339 · Cited by 26
“Standards have been set that relate to the technical quality of PET‐CT and are included in current guidelines.(1) Evaluation of the quality of reading and reporting of PET‐CT scans, however, requires further work, in particular with”
MethodSelf-citationPatient-specific optimisation of administered activity and acquisition times for 18F-FDG PET imaging
Wickham, F., McMeekin, H., Burniston, M., McCool, D., Pencharz, D., Skillen, A., & Wagner, T. (2017) · EJNMMI Research · doi:10.1186/s13550-016-0250-3 · Cited by 25
“The close agreement between the later set of values and those calculated using expressions (3) to (6) arises because the power to which weight is raised in expressions (4) and (6) is close to 1.6 but also reflects the fact that the administered activity and acquisition time required for this scanner to achieve the tar…”
BackgroundInfluentialDolan, R. D., Maclay, J. D., Abbass, T., Colville, D., Buali, F., MacLeod, N., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-77269-7 · Cited by 22
Moving the goalposts while scoring―the dilemma posed by new PET technologies
Rogasch, J. M. M., Boellaard, R., Pike, L., Borchmann, P., Johnson, P., Wolf, J., Barrington, S. F., & Kobe, C. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05403-2 · Cited by 20
“recognized that a reduction in acquisition time could equally well translate into reduced injected activity [97] and therefore into minimized radiation exposure.”
BackgroundSelf-citationImpacts of time interval on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Wang, R., Chen, H., & Fan, C. (2018) · Medicine · doi:10.1097/md.0000000000013122 · Cited by 15
Smeets, E. M. M., Withaar, D. S., Grootjans, W., Hermans, J. J., van Laarhoven, K., de Geus-Oei, L.-F., Gotthardt, M., & Aarntzen, E. H. J. G. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0492-y · Cited by 12
“In this study, we adhered to the 40% SUVmax threshold for tumor delineation which is widely accepted and recommended by the EANM guidelines [38].”
MethodJansen, B. H. E., Jansen, R. W., Wondergem, M., Srbljin, S., de Klerk, J. M. H., Lissenberg-Witte, B. I., Vis, A. N., van Moorselaar, R. J. A., Boellaard, R., Hoekstra, O. S., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.222513 · Cited by 12
Self-citationSørensen, J. S., Vilstrup, M. H., Holm, J., Vogsen, M., Bülow, J. L., Ljungstrøm, L., Braad, P.-E., Gerke, O., & Hildebrandt, M. G. (2020) · Diagnostics · doi:10.3390/diagnostics10121001 · Cited by 10
“Whole-body PET/CT scans were performed following guidelines from EANM [15] on the RX (DRX), STE (DSTE) [16], 690 (D690), 710 (D710) [17], and, MI (DMI) [18] PET/CT Discovery scanners from GE Healthcare (Waukesha, Milwaukee, WI, USA).”
MethodPilz, J., Hehenwarter, L., Zimmermann, G., Rendl, G., Schweighofer-Zwink, G., Beheshti, M., & Pirich, C. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00784-9 · Cited by 6
“Abbreviations ALARA : As low as reasonably achievable; Bw: Body weight; CI: Confidence interval; COV: Coefficient of variation; EANM: European Association of Nuclear Medicine; EARL: EANM Research Ltd; [18F]‑FDG: Fluor‑18 fluoro‑deoxy‑glucose; NECR: Noise equivalent count rate; OSEM: Ordered‑subset expectation maxi‑ mi…”
BackgroundMethodInfluentialBaratto, L., Toriihara, A., Hatami, N., Aparici, C. M., Davidzon, G., Levin, C. S., & Iagaru, A. (2021) · Diagnostics · doi:10.3390/diagnostics11060992 · Cited by 6
Intrapatient variability of 18F-FDG uptake in normal tissues
Sayed, M. H. M., Abdelnaim, A. K., & Mohamadien, N. R. (2022) · Journal of Clinical Imaging Science · doi:10.25259/jcis_23_2022 · Cited by 2
Metadata
- Authors
- Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., Stroobants, S., Delbeke, D., Donohoe, K. J., Holbrook, S., Graham, M. M., Testanera, G., Hoekstra, O. S., Zijlstra, J., Visser, E., Hoekstra, C. J., Pruim, J., Willemsen, A., Arends, B., Kotzerke, J., Bockisch, A., Beyer, T., Chiti, A., & Krause, B. J.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Radboud University Medical Center (NL)
- Hospices Civils de Lyon (FR)
- Städtisches Klinikum Karlsruhe (DE)
- University of Cologne (DE)
- Erasmus MC (NL)
- St Thomas' Hospital (GB)
- Memorial Sloan Kettering Cancer Center (US)
- Antwerp University Hospital (BE)
- Vanderbilt University Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Insilico Medicine (United States) (US)
- University of Iowa (US)
- Humanitas University (IT)
- Jeroen Bosch Ziekenhuis (NL)
- University Medical Center Groningen (NL)
- Catharina Ziekenhuis (NL)
- University Hospital Carl Gustav Carus (DE)
- Essen University Hospital (DE)
- Medical University of Vienna (AT)
- Universitätsmedizin Rostock (DE)
- Corresponding author
- Boellaard, Ronald
- ORCID
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2014-12-02
- Volume
- 42
- Issue
- 2
- Pages
- 328-354
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- PMC
- PMC4315529
- OpenAlex
- W2088783247
- Cited by
- 3,303
- References
- 109
- Citations by year
- 2026: 306 · 2025: 341 · 2024: 388 · 2023: 333 · 2022: 405 · 2021: 408 · 2020: 296 · 2019: 258 · 2018: 230 · 2017: 159 · 2016: 115 · 2015: 54
- FWCI
- 85.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- FDG PET/CT, tumor imaging, standardized uptake value, quantitative imaging, quality control, quality assurance, repeatability, reproducibility, imaging biomarkers, tumor response assessment, tumor staging, cancer diagnosis, cancer prognosis, EANM guidelines
- MeSH terms
- Humans, Neoplasms, Tomography, X-Ray Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.